{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:01:38Z","timestamp":1793044898825,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP19K16703"],"award-info":[{"award-number":["JP19K16703"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GSK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015542","name":"GlaxoSmithKline Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.vaccine.2021.09.042","type":"journal-article","created":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T20:42:05Z","timestamp":1634589725000},"page":"6805-6812","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Laser vaccine adjuvants: Light-augmented immune responses"],"prefix":"10.1016","volume":"39","author":[{"given":"Yohei","family":"Maki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kashiwagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Kimizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2021.09.042_b0005","doi-asserted-by":"crossref","first-page":"392","DOI":"10.4049\/jimmunol.1801054","article-title":"Development of a universal influenza vaccine","volume":"202","author":"Estrada","year":"2019","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2021.09.042_b0010","unstructured":"Centers for Disease Control and Prevention. CDC seasonal flu vaccine effectiveness studies, https:\/\/www.cdc.gov\/flu\/vaccines-work\/effectiveness-studies.htm, [accessed 29 March 2021]."},{"issue":"4","key":"10.1016\/j.vaccine.2021.09.042_b0015","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1586\/erv.11.21","article-title":"Trends in vaccine adjuvants","volume":"10","author":"Schijns","year":"2011","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2021.09.042_b0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.it.2008.09.006","article-title":"New horizons in adjuvants for vaccine development","volume":"30","author":"Reed","year":"2009","journal-title":"Trends Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2021.09.042_b0025","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2021.09.042_b0030","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13223-018-0305-2","article-title":"Unraveling the enigma: elucidating the relationship between the physicochemical properties of aluminium-based adjuvants and their immunological mechanisms of action","volume":"14","author":"Shardlow","year":"2018","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"may27 1","key":"10.1016\/j.vaccine.2021.09.042_b0035","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c2649","article-title":"Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study","volume":"340","author":"Waddington","year":"2010","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.vaccine.2021.09.042_b0040","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/aje\/kwt078","article-title":"Safety of MF59-adjuvanted influenza vaccination in the elderly: results of a comparative study of MF59-adjuvanted vaccine versus nonadjuvanted influenza vaccine in northern Italy","volume":"178","author":"Villa","year":"2013","journal-title":"Am J Epidemiol"},{"issue":"9","key":"10.1016\/j.vaccine.2021.09.042_b0045","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.vaccine.2013.11.031","article-title":"An observer-blind, randomized, multi-center trial assessing long-term safety and immunogenicity of AS03-adjuvanted or unadjuvanted H1N1\/2009 influenza vaccines in children 10\u201317 years of age","volume":"32","author":"Poder","year":"2014","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2021.09.042_b0050","doi-asserted-by":"crossref","first-page":"64","DOI":"10.31138\/mjr.28.2.64","article-title":"The ASIA syndrome: basic concepts","volume":"28","author":"Watad","year":"2017","journal-title":"Mediterr J Rheumatol"},{"issue":"3","key":"10.1016\/j.vaccine.2021.09.042_b0055","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1096\/fj.201902164R","article-title":"Laser adjuvant for vaccination","volume":"34","author":"Kashiwagi","year":"2020","journal-title":"FASEB J"},{"issue":"2","key":"10.1016\/j.vaccine.2021.09.042_b0060","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1089\/pho.2010.2789","article-title":"Mitochondrial mechanisms of photobiomodulation in context of new data about multiple roles of ATP","volume":"28","author":"Karu","year":"2010","journal-title":"Photomed Laser Surg"},{"issue":"5","key":"10.1016\/j.vaccine.2021.09.042_b0065","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1089\/pho.2013.3510","article-title":"Is it time to consider photobiomodulation as a drug equivalent?","volume":"31","author":"Karu","year":"2013","journal-title":"Photomed Laser Surg"},{"issue":"4","key":"10.1016\/j.vaccine.2021.09.042_b0070","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1089\/pho.2005.23.355","article-title":"Exact action spectra for cellular responses relevant to phototherapy","volume":"23","author":"Karu","year":"2005","journal-title":"Photomed Laser Surg"},{"issue":"7","key":"10.1016\/j.vaccine.2021.09.042_b0075","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.4161\/hv.28840","article-title":"Laser vaccine adjuvants. History, progress, and potential","volume":"10","author":"Kashiwagi","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.vaccine.2021.09.042_b0080","doi-asserted-by":"crossref","DOI":"10.4172\/2157-7560.1000307","article-title":"Classification of laser vaccine adjuvants","volume":"7","author":"Kashiwagi","year":"2016","journal-title":"J Vaccines Vaccin"},{"issue":"2","key":"10.1016\/j.vaccine.2021.09.042_b0085","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/eye.2015.252","article-title":"What is light?","volume":"30","author":"Sliney","year":"2016","journal-title":"The visible spectrum and beyond. Eye (Lond)"},{"key":"10.1016\/j.vaccine.2021.09.042_b0090","doi-asserted-by":"crossref","unstructured":"Heiskanen V, Hamblin MR. Photobiomodulation: lasers vs. light emitting diodes? Photochem Photobiol Sci 2018;17(8):1003\u201317. DOI: 10.1039\/c8pp90049c.","DOI":"10.1039\/c8pp00176f"},{"issue":"23","key":"10.1016\/j.vaccine.2021.09.042_b0095","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJM197412052912301","article-title":"Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light","volume":"291","author":"Parrish","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2021.09.042_b0100","doi-asserted-by":"crossref","unstructured":"Fitzpatrick TB, Pathak MA. Historical aspects of methoxsalen and other furocoumarins. J Invest Dermatol 1959;32(2, Part 2):229\u201331.","DOI":"10.1038\/jid.1959.40"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2021.09.042_b0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/1011-1344(92)85080-E","article-title":"The evolution of photochemotherapy with psoralens and UVA (PUVA): 2000 BC to 1992 AD","volume":"14","author":"Pathak","year":"1992","journal-title":"J Photochem Photobiol B"},{"issue":"2","key":"10.1016\/j.vaccine.2021.09.042_b0110","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jaad.2020.04.095","article-title":"Role of phototherapy in the era of biologics","volume":"84","author":"Torres","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"17","key":"10.1016\/j.vaccine.2021.09.042_b0115","doi-asserted-by":"crossref","first-page":"14599","DOI":"10.1364\/OE.17.014599","article-title":"Chromophore concentrations, absorption and scattering properties of human skin in-vivo","volume":"17","author":"Tseng","year":"2009","journal-title":"Opt Express"},{"issue":"118","key":"10.1016\/j.vaccine.2021.09.042_b0120","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2475\/ajs.s3-20.118.305","article-title":"On the production and reproduction of sound by light","volume":"s3-20","author":"Bell","year":"1880","journal-title":"Am J Sci"},{"key":"10.1016\/j.vaccine.2021.09.042_b0125","doi-asserted-by":"crossref","unstructured":"Terazima M, Hirota N, Braslavsky SE, Mandelis A, Bialkowski SE, Diebold GJ, et al. Quantities, terminology, and symbols in photothermal and related spectroscopies (IUPAC Recommendations 2004). Pure Appl Chem 2004;76(6):1083\u2013118. DOI: 10.1351\/pac200476061083.","DOI":"10.1351\/pac200476061083"},{"issue":"9","key":"10.1016\/j.vaccine.2021.09.042_b0130","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/ped.13332","article-title":"Phototherapy for neonatal hyperbilirubinemia","volume":"59","author":"Itoh","year":"2017","journal-title":"Pediatr Int"},{"issue":"1","key":"10.1016\/j.vaccine.2021.09.042_b0135","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1751-1097.1991.tb08463.x","article-title":"Quantum yields for the cyclization and configurational isomerization of 4E,15Z-bilirubin","volume":"53","author":"Ennever","year":"1991","journal-title":"Photochem Photobiol"},{"issue":"4","key":"10.1016\/j.vaccine.2021.09.042_b0140","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2203\/dose-response.09-027.Hamblin","article-title":"Biphasic dose response in low level light therapy","volume":"7","author":"Huang","year":"2009","journal-title":"Dose Response"},{"issue":"4","key":"10.1016\/j.vaccine.2021.09.042_b0145","doi-asserted-by":"crossref","first-page":"602","DOI":"10.2203\/dose-response.11-009.Hamblin","article-title":"Biphasic dose response in low level light therapy - an update","volume":"9","author":"Huang","year":"2011","journal-title":"Dose Response"},{"key":"10.1016\/j.vaccine.2021.09.042_b0150","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1038\/ncomms5447","article-title":"A micro-sterile inflammation array as an adjuvant for influenza vaccines","volume":"5","author":"Wang","year":"2014","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.vaccine.2021.09.042_b0155","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.4049\/jimmunol.1500564","article-title":"Laser-assisted intradermal delivery of adjuvant-free vaccines targeting XCR1+ dendritic cells induces potent antitumoral responses","volume":"194","author":"Terhorst","year":"2015","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2021.09.042_b0160","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jconrel.2012.01.002","article-title":"Facilitation of transcutaneous drug delivery and vaccine immunization by a safe laser technology","volume":"159","author":"Chen","year":"2012","journal-title":"J Control Release"},{"issue":"16","key":"10.1016\/j.vaccine.2021.09.042_b0165","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1073\/pnas.1500408112","article-title":"Effective and lesion-free cutaneous influenza vaccination","volume":"112","author":"Wang","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.vaccine.2021.09.042_b0170","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1021\/acs.accounts.9b00273","article-title":"Near-infrared photoimmunotherapy of cancer","volume":"52","author":"Kobayashi","year":"2019","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.vaccine.2021.09.042_b0175","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.biopha.2018.07.049","article-title":"Photodynamic therapy - mechanisms, photosensitizers and combinations","volume":"106","author":"Kwiatkowski","year":"2018","journal-title":"Biomed Pharmacother."},{"key":"10.1016\/j.vaccine.2021.09.042_b0180","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jconrel.2020.06.032","article-title":"Photothermal therapy","volume":"325","author":"Zhi","year":"2020","journal-title":"J Control Release."},{"issue":"25","key":"10.1016\/j.vaccine.2021.09.042_b0185","doi-asserted-by":"crossref","first-page":"10049","DOI":"10.1073\/pnas.1309653110","article-title":"Under the skin of intradermal vaccines","volume":"110","author":"Williams","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2021.09.042_b0190","first-page":"32","article-title":"Diagnostics and correction of the metabolic and immune disorders","volume":"1","author":"Onikienko","year":"2007","journal-title":"Interact Bacterial Endotoxins Lipophilic Xenobiot Recept Assoc Innate Immun Donosologiya (St Petersburg)"},{"issue":"10","key":"10.1016\/j.vaccine.2021.09.042_b0195","doi-asserted-by":"crossref","first-page":"e13776","DOI":"10.1371\/journal.pone.0013776","article-title":"A novel laser vaccine adjuvant increases the motility of antigen presenting cells","volume":"5","author":"Chen","year":"2010","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1016\/j.vaccine.2021.09.042_b0200","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1158\/1078-0432.CCR-11-2654","article-title":"Improved efficacy of dendritic cell-based immunotherapy by cutaneous laser illumination","volume":"18","author":"Chen","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.vaccine.2021.09.042_b0205","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.vaccine.2012.10.069","article-title":"High immunogenicity of nicotine vaccines obtained by intradermal delivery with safe adjuvants","volume":"31","author":"Chen","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.09.042_b0210","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jconrel.2015.02.031","article-title":"Laser mimicking mosquito bites for skin delivery of malaria sporozoite vaccines","volume":"204","author":"Zhou","year":"2015","journal-title":"J Control Release"},{"issue":"12","key":"10.1016\/j.vaccine.2021.09.042_b0215","doi-asserted-by":"crossref","first-page":"e82899","DOI":"10.1371\/journal.pone.0082899","article-title":"Near-infrared laser adjuvant for influenza vaccine","volume":"8","author":"Kashiwagi","year":"2013","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.vaccine.2021.09.042_b0220","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1562\/0031-8655(2001)074<0656:THOPAP>2.0.CO;2","article-title":"The history of photodetection and photodynamic therapy","volume":"74","author":"Ackroyd","year":"2001","journal-title":"Photochem Photobiol"},{"issue":"4","key":"10.1016\/j.vaccine.2021.09.042_b0225","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.clindermatol.2011.11.019","article-title":"From patient to discoverer\u2014Niels Ryberg Finsen (1860\u20131904)\u2014the founder of phototherapy in dermatology","volume":"30","author":"Grzybowski","year":"2012","journal-title":"Clin Dermatol"},{"issue":"4","key":"10.1016\/j.vaccine.2021.09.042_b0230","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.4049\/jimmunol.1601873","article-title":"Near-infrared 1064-nm laser modulates migratory dendritic cells to augment the immune response to intradermal influenza vaccine","volume":"199","author":"Morse","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2021.09.042_b0235","doi-asserted-by":"crossref","unstructured":"Yokomizo S, Katagiri W, Maki Y, Sano T, Inoue K, Fukushi M, et al. Brief exposure of skin to near-infrared laser augments early vaccine responses. Nanophotonics 2021;in press: pp. 000010151520210133. https:\/\/doi.org\/10.1515\/nanoph-2021-0133.","DOI":"10.1515\/nanoph-2021-0133"},{"issue":"12","key":"10.1016\/j.vaccine.2021.09.042_b0240","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.4049\/jimmunol.1701687","article-title":"Brief exposure of skin to near-infrared laser modulates mast cell function and augments the immune response","volume":"201","author":"Kimizuka","year":"2018","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2021.09.042_b0245","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1096\/fj.201801095R","article-title":"A pilot clinical trial of a near-infrared laser vaccine adjuvant: safety, tolerability, and cutaneous immune cell trafficking","volume":"33","author":"Gelfand","year":"2019","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.vaccine.2021.09.042_b0250","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0304-3835(97)04707-1","article-title":"Laser-photosensitizer assisted immunotherapy: a novel modality for cancer treatment","volume":"115","author":"Chen","year":"1997","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.vaccine.2021.09.042_b0255","doi-asserted-by":"crossref","first-page":"1630001","DOI":"10.1142\/S1793545816300019","article-title":"Photonics immunotherapy\u2014a novel strategy for cancer treatment","volume":"09","author":"Zhou","year":"2016","journal-title":"J Innov Opt Health Sci"},{"issue":"21","key":"10.1016\/j.vaccine.2021.09.042_b0260","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.1158\/1078-0432.CCR-18-1126","article-title":"Local phototherapy synergizes with immunoadjuvant for treatment of pancreatic cancer through induced immunogenic tumor vaccine","volume":"24","author":"Zhou","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"04","key":"10.1016\/j.vaccine.2021.09.042_b0265","doi-asserted-by":"crossref","first-page":"1350039","DOI":"10.1142\/S1793545813500399","article-title":"Anti-tumor responses induced by laser irradiation and immunological stimulation using a mouse mammary tumor model","volume":"06","author":"Zhou","year":"2013","journal-title":"J Innov Opt Health Sci"},{"issue":"8","key":"10.1016\/j.vaccine.2021.09.042_b0270","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1080\/02656736.2018.1446221","article-title":"Laser immunotherapy for cutaneous squamous cell carcinoma with optimal thermal effects to enhance tumour immunogenicity","volume":"34","author":"Luo","year":"2018","journal-title":"Int J Hyperthermia"},{"issue":"5","key":"10.1016\/j.vaccine.2021.09.042_b0275","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/jbio.201600271","article-title":"Treatment of advanced melanoma with laser immunotherapy and ipilimumab","volume":"10","author":"Naylor","year":"2017","journal-title":"J Biophotonics"},{"issue":"2","key":"10.1016\/j.vaccine.2021.09.042_b0280","doi-asserted-by":"crossref","first-page":"e201800149","DOI":"10.1002\/jbio.201800149","article-title":"Photothermal therapy enhanced the effectiveness of imiquimod against refractory cutaneous warts through boosting immune responses","volume":"12","author":"Shi","year":"2019","journal-title":"J Biophotonics"},{"issue":"4736","key":"10.1016\/j.vaccine.2021.09.042_b0285","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/187493a0","article-title":"Stimulated optical radiation in ruby","volume":"187","author":"Maiman","year":"1960","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.vaccine.2021.09.042_b0290","doi-asserted-by":"crossref","first-page":"56","DOI":"10.15171\/jlms.2017.11","article-title":"Low-level laser therapy in Russia: history, science and practice","volume":"8","author":"Moskvin","year":"2017","journal-title":"J Lasers Med Sci"},{"issue":"3","key":"10.1016\/j.vaccine.2021.09.042_b0295","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0965-206X(01)80039-5","article-title":"Lasers in plastic surgery","volume":"11","author":"Khan","year":"2001","journal-title":"J Tissue Viability"},{"key":"10.1016\/j.vaccine.2021.09.042_b0300","doi-asserted-by":"crossref","unstructured":"Saedi N, Petelin A, Zachary C. Fractionation: a new era in laser resurfacing. Clin Plast Surg 2011;38(3):449\u201361, vii. DOI: 10.1016\/j.cps.2011.02.008.","DOI":"10.1016\/j.cps.2011.02.008"},{"issue":"1","key":"10.1016\/j.vaccine.2021.09.042_b0305","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.fsc.2019.09.008","article-title":"Picosecond laser: tattoos and skin rejuvenation","volume":"28","author":"Saluja","year":"2020","journal-title":"Facial Plast Surg Clin North Am"},{"issue":"18","key":"10.1016\/j.vaccine.2021.09.042_b0310","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1016\/j.vaccine.2017.03.036","article-title":"Semiconductor diode laser device adjuvanting intradermal vaccine","volume":"35","author":"Kimizuka","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.09.042_b0315","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3389\/fimmu.2013.00157","article-title":"Skin-resident antigen-presenting cells: instruction manual for vaccine development","volume":"4","author":"Fehres","year":"2013","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2021.09.042_b0320","doi-asserted-by":"crossref","first-page":"811","DOI":"10.4161\/hv.7.8.16274","article-title":"Transcutaneous and intradermal vaccination","volume":"7","author":"Combadiere","year":"2011","journal-title":"Hum Vaccin"},{"issue":"1","key":"10.1016\/j.vaccine.2021.09.042_b0325","first-page":"7","article-title":"The intradermal vaccination: past experiences and current perspectives","volume":"51","author":"Sticchi","year":"2010","journal-title":"J Prev Med Hyg"},{"issue":"9","key":"10.1016\/j.vaccine.2021.09.042_b0330","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.vaccine.2015.01.025","article-title":"Safety and immunogenicity of a quadrivalent intradermal influenza vaccine in adults","volume":"33","author":"Gorse","year":"2015","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2021.09.042_b0335","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1473-3099(20)30555-7","article-title":"Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trial","volume":"21","author":"Bandyopadhyay","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"27","key":"10.1016\/j.vaccine.2021.09.042_b0340","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1016\/j.vaccine.2018.05.028","article-title":"A phase 1 study of safety and immunogenicity following intradermal administration of a tetravalent dengue vaccine candidate","volume":"36","author":"Jackson","year":"2018","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2021.09.042_b0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119629","article-title":"Priming with a simplified intradermal HIV-1 DNA vaccine regimen followed by boosting with recombinant HIV-1 MVA vaccine is safe and immunogenic: a phase IIa randomized clinical trial","volume":"10","author":"Munseri","year":"2015","journal-title":"PLoS ONE"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21012330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21012330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:02:16Z","timestamp":1759402936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21012330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":69,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0264410X21012330"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.09.042","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Laser vaccine adjuvants: Light-augmented immune responses","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.09.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}